• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • Write for us
  • Contact us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Obstetrics

Lung recruitment improves efficacy of surfactant treatment in extremely preterm neonates

byVineeth BhogadiandArnav Agarwal, MD
August 3, 2020
in Obstetrics, Pediatrics, Pulmonology
Reading Time: 2 mins read
0
Share on FacebookShare on Twitter

1. The intubation-recruitment-surfactant administration-extubation procedure reduced the need for invasive ventilation in extremely preterm neonates compared to those not receiving lung recruitment.

2. There were no adverse effect on safety outcomes including in-hospital mortality, pneumothorax and intraventricular hemorrhage.

Evidence Rating Level: 1 (Excellent)

Study Rundown: Early surfactant administration is the most effective strategy for respiratory distress syndrome in neonates. These neonates are typically administered surfactant with the intubation-surfactant-extubation (IN-SUR-E) strategy. The IN-SUR-E technique may not be successful due to lung de-recruitment during intubation resulting in impaired surfactant distribution and efficacy. However, few studies have investigated the utility of lung recruitment procedures prior to surfactant administration in human infants.

This randomized controlled trial included 218 infants born in 35 tertiary neonatal intensive care units in Italy with gestational ages between 24+0 and 27+6 weeks. Results suggested that neonates receiving the intubation-recruitment-surfactant administration-extubation (IN-REC-SUR-E) strategy were less likely to require invasive ventilation within the first 72 hours of life compared to the IN-SUR-E group. Additionally, there were no significant differences between IN-REC-SUR-E and IN-SUR-E treated infants with regard to safety outcomes and in hospital mortality. This study was limited by its unblinded design and stringent eligibility criteria limiting generalizability of findings. Further adequately powered studies are required to identify whether the IN-SEC-SUR-E technique confers a survival benefit and its impact on long-term respiratory outcomes.

Click to read the study in The Lancet Respiratory Medicine

Relevant Reading: Surfactant replacement therapy for preterm and term neonates with respiratory distress

RELATED REPORTS

Laryngeal mask airway is suitable method for surfactant administration in infants with respiratory distress syndrome

Half-dose antenatal betamethasone is inferior to full dose for preventing usage of neonatal surfactant

Late and moderate preterm birth associated with increased cardiometabolic risk scores in young children

In-Depth [randomized controlled trial]: This study included 218 infants born between 24+0 weeks and 27+6 weeks gestational age at 35 tertiary neonatal intensive care units in Italy between 2015 and 2018. Neonates with severe birth asphyxia, 5-minute Apgar scores less than 3 or requiring endotracheal intubation in the delivery room for resuscitation were excluded from the study. Infants were given surfactant if their clinical status deteriorated rapidly while on nasal CPAP, developed respiratory acidosis or if they required an FiO2 of >0.30 to maintain oxygen saturations between 87-94%. Infants assigned to the IN-SEC-SUR-E technique received high frequency oscillatory ventilation with an oxygen guided lung recruitment procedure using stepwise increments followed by decrements in mean airway pressure to recruit and stabilise collapsed alveoli. The primary outcome was need for invasive ventilation within 72 hours of life.

Overall, 40% (43 of 107) of infants in the IN-REC-SUR-E group required invasive ventilation within 72 hours of life compared to 54% (60 of 111) of infants in the IN-SUR-E group (relative risk (RR) 0.75, 95% CI 0.57 to 0.98, p=0.037; number needed to treat [NNT] 7.2, 95% CI 3.7 to 135.0). The main indications for invasive ventilation was acute respiratory failure in both groups (84% and 85%, respectively). In-hospital mortality occurred in 21% (23 of 107) and 33% (37 of 111) of infants, respectively (RR 0.64, 95% CI 0.41 to 1.01, p=0.055). There were no significant differences in incidences of pneumothorax (RR 0.59, 95% CI 0.18 to 1.97, p=0.39), pulmonary hemorrhage (RR 0.92, 95% CI 0.37 to 2.30, p=0.86) and grade 2+ intraventricular hemorrhage (RR 0.73, 95% CI 0.37 to 1.46, p=0.38) between treatment groups; safety profiles were comparable.

Image: PD

©2020 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: APGARlung recruitmentpretermsurfactant
Previous Post

Neonatal outcomes in 29 pregnant women with COVID-19: A retrospective study in Wuhan, China

Next Post

Hydroxychloroquine and azithromycin do not improve clinical outcomes in mild-to-moderate Covid-19

RelatedReports

Distinct NICU newborn naming linked to reduced error
Pediatrics

Laryngeal mask airway is suitable method for surfactant administration in infants with respiratory distress syndrome

November 3, 2022
Digital imaging detects sight-threatening retinopathy of prematurity
Obstetrics

Half-dose antenatal betamethasone is inferior to full dose for preventing usage of neonatal surfactant

August 31, 2022
Early language exposure is predictive of language skills and IQ in school-age children
Cardiology

Late and moderate preterm birth associated with increased cardiometabolic risk scores in young children

June 1, 2022
Neonatal neuroimaging with strong negative predictive value for developmental outcomes: The NEURO study
Pediatrics

Enteric administration of recombinant human insulin to preterm infants is safe and effective

April 4, 2022
Next Post
SARS-CoV-2 detected on various surroundings of asymptomatic COVID-19 positive infant

Hydroxychloroquine and azithromycin do not improve clinical outcomes in mild-to-moderate Covid-19

#VisualAbstract: Novel SARS-CoV-2 vaccine (ChAdOx1 nCoV-2) offers promising safety and immunogenicity

#VisualAbstract: Novel SARS-CoV-2 vaccine (ChAdOx1 nCoV-2) offers promising safety and immunogenicity

Effectiveness of the ready to reduce risk (3r) complex intervention for the primary prevention of cardiovascular disease

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.

LICENSE CONTENT

2MM+ Premium Access

No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.

Subscription Options
2 Minute Medicine

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Deep intronic FGF14 repeat expansion associated with late-onset cerebella ataxia
  • Plant-based diets may be associated with lower risk of aggressive prostate cancer
  • #VisualAbstract: Adagrasib provides antitumour activity against KRAS G12C mutant metastatic colorectal cancer both as monotherapy and in combination with cetuximab
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

Want more physician-written
medical news?

Join over 10 million yearly readers and numerous companies. For healthcare professionals
and the public.

Subscribe for free today!

Subscription options